A Prospective Safety Sub-Registsry to Assess Anaphylaxis and Severe Allegric Reactions and Severe Cutaneious and Systemic Immune-mediated Reactions with Alglucosidase Alfa Treatment
Clinical Trial Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Genzyme Corporation
Start Date
October 10, 2016
End Date
September 30, 2021
Administered By
Pediatrics, Medical Genetics
Awarded By
Genzyme Corporation
Start Date
October 10, 2016
End Date
September 30, 2021